Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

Trial ID or NCT#



recruiting iconRECRUITING


The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.

Official Title

Confounder-Corrected Quantitative Magnetic Resonance Imaging (MRI) Biomarker of Hepatic Iron Content

Eligibility Criteria

Ages Eligible for Study: 8 Years to 89 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - know or suspected iron overload - minimum age: Stanford- 8years , University of Wisconsin - 10 years, John Hopkins follow- 10 years, University of Texas-Southwestern - 18 years
Exclusion Criteria:
  1. - contraindication to magnetic resonance imaging


Shreyas Vasanawala, MD/PhD
Shreyas Vasanawala, MD/PhD
William R. Brody Professor of Pediatric Radiology and Child Health

Contact us to find out if this trial is right for you.


Elisabeth Merkel, RN